PEN:NYSE
Penumbra Inc
318,34 US$
arrow_downward
-0,16%(-0,52) 1K
318,34 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 30-sen, 16:00:04 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoPEN tikeri uchun statistika yaratilmoqda...
Ochish
318,51 US$
Yuqori
319,19 US$
Past
318,24 US$
Bozor kapitali
12,54 mlrd
Oʻrtacha hajm
343,78 ming
Hajmi
0,00
P/E koeffitsiyenti
78,19
52 haftalik eng yuqori
362,41 US$
52 haftalik eng past
221,26 US$
Aksiya boʻyicha daromad
4,07 US$
Beta
0,70
Muomaladagi aksiyalar
39,39 mln
Xodimlar soni
5 ming
Ochish
318,51 US$
Yuqori
319,19 US$
Past
318,24 US$
Bozor kapitali
12,54 mlrd
Oʻrtacha hajm
343,78 ming
Hajmi
0,00
P/E koeffitsiyenti
78,19
52 haftalik eng yuqori
362,41 US$
52 haftalik eng past
221,26 US$
Aksiya boʻyicha daromad
4,07 US$
Beta
0,70
Muomaladagi aksiyalar
39,39 mln
Xodimlar soni
5 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
1 kun oldin
IART or PEN: Which Is the Better Value Stock Right Now?
Profil
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
Penumbra Inc haqida